Schnitzel lover
Regular
I’m of the same opinion.Yes, the 1H23 report reflects a lacklustre 6 months for the company from a sales perspective.
How some shareholders on here were expecting anything different though is beyond me. What company in their right mind was going to sign an IP licence with Brainchip in the first half of 2023 when Akida 2.0 benefits are right around the corner? As Sean noted in the AGM, the second generation of Akida with its incredible improvements and additional functionality, was developed as a result of direct feedback from customers as to their requirements.
Considering lead adopters have been engaged with the benefits of Akida 2.0 for a short while now with general availability supposedly available now as per @Fact Finder recent post, we should surely be expecting some sales conversions. My personal timeframe to start seeing some more numbers on the boards (IP licences) is 6-12 months. We've been patient. Leeway has been given for much longer than anticipated but with the release of the 2.0 platform, there are no more excuses to deliver tangible, financial results.
Next AGM will be 6-7 months with Gen 2 available on the market.
Even if the product cycle is 3-4 years or bust, that should’ve entail time is of the essence and a partner signing an IP to streamline that cycle is imperative.
And to be frank I don’t buy the theory of partners not taking out IP licenses because they can go through their chip makers who hold Akida IP licenses. These Chip makers and end users development through chip makers in Renesas and Megachips will have had 3-4 years as of this time next year to develop products.
So shelve Gen 3 commercially and market availability-wise until these partners have products in the market producing royalties for BRN. Then let them knock the door down to get Gen 3 improvements. After all, there’s supposedly nothing else on market within a 3-5yr window with the same capabilities.
There’s no way shareholders will accept similar results at the next AGM. It will be a metaphorical bloodbath in my view for the current BOD, executive and non-executive.
I would’ve thought the H2 Dec 2023 financials will be pivotal for the company, good or bad.
All in my opinion and DYOR